RENAISSANCE TECHNOLOGIES LLC

Position in RANI — Rani Therapeutics Holdings, Inc.

CIK 1037389 NEW YORK, NY

Position in RANI

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$327,360

+$314,906 QoQ

Shares Held

430,737

+1629.3% QoQ

Ownership

0.309%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#15

of 67 holders

Holding Since

Dec 2022

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,952,560,012 across 312 Biotechnology names. RANI ranks #234 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,427,993	$730,617,099
2	CORT	Corcept Therapeutics Inc	5,261,628	$457,498,554
3	INCY	Incyte Corp	3,512,132	$398,135,283
4	VRTX	Vertex Pharmaceuticals Inc / Ma	320,008	$158,957,573
5	JAZZ	Jazz Pharmaceuticals plc	562,073	$135,442,730
6	RPRX	Royalty Pharma plc	1,935,800	$108,540,306
7	TVTX	Travere Therapeutics, Inc.	1,833,079	$104,137,217
8	GMAB	Genmab A/S	3,517,850	$96,635,339

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$327,360	430,737	+1629.3%	Shares	Sole	2026-08-13
2025-09-30	$12,454	24,908	-25.0%	Shares	Sole	2025-11-13
2024-09-30	$71,709	33,199	+53.0%	Shares	Sole	2024-11-13
2024-06-30	$82,460	21,700	-69.1%	Shares	Sole	2024-08-09
2024-03-31	$218,633	70,300	+60.9%	Shares	Sole	2024-05-13
2023-12-31	$145,084	43,700	-14.3%	Shares	Sole	2024-02-13
2023-09-30	$110,925	51,000	-42.2%	Shares	Sole	2023-11-14
2023-06-30	$363,388	88,201	+114.5%	Shares	Sole	2023-08-11
2023-03-31	$212,163	41,117	+7.1%	Shares	Sole	2023-05-12
2022-12-31	$226,560	38,400	—	Shares	Sole	2023-02-13
No filing history on record for this holder in this stock.